Cellares raises $255M as it prepares to manufacture cell therapies

Cellares, which is known for producing the technology used in cell therapy manufacturing, has raised $255 million in a Series C as it aims to build out its own manufacturing business.

Fabian Gerlinghaus

The company’s thinking is that contract manufacturers are not currently able…
Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks